The latest joint report from the Physicians Coalition for Injectable Safety and the Partnership for Safe Medicines tallies up instances of counterfeit product sales and unlicensed practitioners in the segment.
Allergan has long dominated the anti-wrinkle arena with its Botox product, but it appears cosmo-pharma giant Johnson & Johnson is preparing to offer serious competition, with the development of its latest drug.
Mentor Corporation says it has begun a Phase 2 dose-finding study
for its botulinum toxin type A product focused on cosmetic
indications in the US - a move that aims to tap into the still
growing market for non-surgical anti-aging...
Mentor, a global supplier of medical products, says it has
initiated an initial study of its proprietary botulinum toxin type
A product, focused on the cosmetic applications for the US market.
The company says that the study aims...